Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections
Authors:
- Richard M GesserRGRichard M Gesser
- Kathleen A McCarrollKMKathleen A McCarroll
- Gail L WoodsGWGail L Woods
- 1 January 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Infection
- Vol. 48 (1) , 32-38
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Ertapenem Once a Day Versus Piperacillin–Tazobactam Every6 Hours for Treatment of Acute Pelvic Infections:A Prospective, Multicenter, Randomized, Double‐Blind StudyInfectious Diseases in Obstetrics and Gynecology, 2002
- Ertapenem Once Daily Versus Piperacillin‐Tazobactam 4 Times per Day for Treatment of Complicated Skin and Skin‐Structure Infections in Adults: Results of a Prospective, Randomized, Double‐Blind Multicenter StudyClinical Infectious Diseases, 2002
- Ambulatory antimicrobial use: the value of an outcomes registryJournal of Antimicrobial Chemotherapy, 2002
- In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and AustraliaAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical CentersAntimicrobial Agents and Chemotherapy, 2001
- Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapyClinical Microbiology and Infection, 2000
- Ambulatory Use of Parenteral AntibacterialsDrugs, 2000
- Outpatient Parenteral Antimicrobial-Drug TherapyNew England Journal of Medicine, 1997
- Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USAEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- General Guidelines for the Clinical Evaluation of Anti-Infective Drug ProductsClinical Infectious Diseases, 1992